SPTLC1 and amyotrophic lateral sclerosis: Recently, causal mutations in SPTLC1, which encodes serine palmitoyltransferase (SPT) long-chain base subunit 1 that is important for sphingolipid biosynthesis, have been identified in ALS [16, 17], suggesting that deficits in lipid metabolism could drive ALS pathogenesis.